Schrader, Jil <br/><br/>
The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.  [electronic resource] 

 -  Science (New York, N.Y.)  Aug 2016 
 - 594-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-9203 
<br/><br/><label>Standard No.: </label>10.1126/science.aaf8993  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--chemistry<br/>Biocatalysis--drug effects<br/>Boron Compounds--chemistry<br/>Boronic Acids--chemistry<br/>Bortezomib--chemistry<br/>Catalytic Domain--drug effects<br/>Crystallography, X-Ray<br/>Drug Design<br/>Glycine--analogs & derivatives<br/>Humans<br/>Proteasome Endopeptidase Complex--chemistry<br/>Proteasome Inhibitors--chemistry<br/>Protein Conformation<br/>Threonine--analogs & derivatives